Psychiatry and Neurology, Neurology · Atlanta, GA
NPI
1013900919
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
7
Hospital affiliations
12 Executive Park Drive
Atlanta, GA, 30329
Phone (404) 778-3444
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
350 services
Medicare patients, 2024
230
Average age 66
Drug cost, 2024
$8.6M
4,250 prescriptions
Company payments, 2025
$78.97
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neil S Lava was code 99213 (office e&m - established), 168 times for 131 patients. In total Neil S Lava billed 350 services in 6 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 168 | 131 | $53.12 | $8,924 |
| 99214 Office E&M - Established | Office | 107 | 86 | $70.77 | $7,572 |
| 99215 Office E&M - Established | Office | 31 | 28 | $109.84 | $3,405 |
| 99204 Office E&M - New | Office | 21 | 21 | $114.54 | $2,405 |
| 99212 Office E&M - Established | Office | 13 | 13 | $35.21 | $458 |
By year: 2022 $33K for 375 services; 2023 $28K for 344 services; 2024 $24K for 350 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neil S Lava prescribed most often to Medicare patients was Gabapentin, with 393 prescriptions and refills. In total Neil S Lava wrote 4,250 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 393 | 623 | 96 | $8,271 |
| Kesimpta Pen Ofatumumab | 246 | 250 | 32 | $2.2M |
| Baclofen Generic | 231 | 418 | 60 | $6,121 |
| Tizanidine Hcl Generic | 155 | 263 | 33 | $1,327 |
| Oxcarbazepine Generic | 141 | 304 | 41 | $8,899 |
| Pregabalin Generic | 115 | 159 | 22 | $2,698 |
| Trazodone Hcl Generic | 114 | 182 | 28 | $410 |
| Levetiracetam Generic | 96 | 181 | 23 | $2,286 |
| Topiramate Generic | 95 | 200 | 32 | $785 |
| Dimethyl Fumarate Generic | 91 | 101 | 11 | $176K |
| Diazepam Generic | 79 | 79 | 18 | $356 |
| Dalfampridine Er Dalfampridine | 73 | 89 | Under 11 | $42K |
| Methylphenidate Hcl Generic | 64 | 64 | 12 | $823 |
| Avonex Pen (4 Pack) Interferon Beta-1a | 64 | 64 | Under 11 | $510K |
| Mayzent Siponimod | 62 | 62 | Under 11 | $553K |
Brand drugs: 918 claims; generic drugs: 3,332 claims; opioid claims: 189.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neil S Lava $78.97 ($78.97 in general payments such as food, travel and fees) from 1 company. The largest payer was Biogen, Inc. with $78.97.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 1 | $78.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.